Antiresorptive Therapy to Reduce Fracture Risk and Effects on Dental Implant Outcomes in Patients With Osteoporosis: A Systematic Review and Osteonecrosis of the Jaw Taskforce Consensus Statement.
Ali DS, Khan AA, Morrison A, Tetradis S, Mirza RD, El Rabbany M, Abrahamsen B, Aghaloo TL, Al-Alwani H, Al-Dabagh R, Anastasilakis AD, Bhandari M, Body JJ, Brandi ML, Brignardello-Petersen R, Brown JP, Cheung AM, Compston J, Cooper C, Diez-Perez A, Ferrari SL, Guyatt G, Hanley D, Harvey NC, Josse RG, Kendler DL, Khan S, Kim S, Langdahl BL, Magopoulos C, Masri BK, Morgan SL, Morin SN, Napoli N, Obermayer-Pietsch B, Palermo A, Pepe J, Peters E, Pierroz DD, Rizzoli R, Saunders DP, Stanford CM, Sulimani R, Taguchi A, Tanaka S, Watts NB, Zamudio J, Zillikens MC, Ruggiero SL.
Ali DS, et al. Among authors: napoli n.
Endocr Pract. 2025 May;31(5):686-698. doi: 10.1016/j.eprac.2025.02.016.
Endocr Pract. 2025.
PMID: 40335186
Free article.
Review.